TAIPEI, Taiwan – How to attract capital is a well-trod theme in the biopharma sector, but the best investors bring more than just money to the table, speakers noted during the Asia Pacific Biotech Investment Forum last week. The right kind of business know-how could help turn a company with a good idea and solid research into a unicorn, a startup with a valuation of $1 billion.